Vinva Investment Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,602
Closed -$244K 460
2025
Q4
$244K Sell
1,602
-7,207
-82% -$579K ﹤0.01% 384
2025
Q3
$715K Buy
8,809
+5,346
+154% +$267K 0.01% 352
2025
Q2
$285K Buy
+3,463
New +$176K 0.01% 390
2024
Q1
Sell
-7,061
Closed -$535K 428
2023
Q4
$535K Sell
7,061
-16,381
-70% -$1.07M 0.04% 326
2023
Q3
$1.62M Buy
23,442
+9,280
+66% +$787K 0.15% 152
2023
Q2
$1.34M Buy
+14,162
New +$1.1M 0.11% 197

Other funds holding EXAS

Vinva Investment Management's EXAS Position: Q1 2026 in Review

Vinva Investment Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,602 shares — an estimated $244K sold.

Vinva Investment Management first reported a position in EXAS in Q2 2023 and held it in 6 quarters. The position peaked at $1.62M in Q3 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Vinva Investment Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Vinva Investment Management sold 1,602 Exact Sciences shares in Q1 2026, an estimated $244K.
  • Vinva Investment Management first reported a position in Exact Sciences in Q2 2023 and held it in 6 quarters.
  • Vinva Investment Management's Exact Sciences position peaked at $1.62M in Q3 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.